JOHANNESBURG (Reuters) – Africa’s top public health agency is still talking to pharmaceutical firms Merck and Pfizer about obtaining supplies of their antiviral pills to treat COVID-19, its director said on Thursday.
“We are still in discussions with both Pfizer and Merck, so there’s no new development that I can share. These discussions take long,” said John Nkengasong, head of the Africa Centres for Disease Control and Prevention (CDC), at a regular online briefing.
(Reporting by Alexander Winning and James Macharia Chege; Writing by Estelle Shirbon)
